Maze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, ...

One pharmaceutical merger stopped by the FTC was Sanofi’s $750m licensing agreement with US-based biotech Maze Therapeutics, ...

Campus Chemical Instrument Center, Mass Spectrometry & Proteomics Facility, The Ohio State University, Columbus, USA ...